Applications Published 29 November 2000
Published: 25-Jul-2001
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Topiramate and related derivatives for treating schizophrenia
Ortho-McNeil Pharmaceutical 1054663*Method for modulating macrophage activation
Neurochem 1053664*Pharmaceutical compsn comprising a combination of metformin and fibrate, and its use for the treatment of hyperglycaemia
Merck Patent 1054665*Liquid pharmaceutical formulation containing zotepine
Knoll 1054666*Bicyclic pyrrole compounds, pharmaceutical compsns containing them and their use as antiinflammatory and immunomodulating agents
AstraZeneca 1054667*Use of a glutamate release inhibitor in the treatment of retinal ischaemia
Centre National de la Recherche Scientifique 1054668*Use of thiadiazolo(4,3-A)pyridine derivatives
Roche Diagnostics 1054669*Use of chelating agents in the treatment of atherosclerotic conditions
Nycomed Imaging 1054670*New use for pain management
AstraZeneca 1054671*Morphine sulphate microgranules, method for making same and pharmaceutical preparations
Laboratoires des Produits Ethiques Ethypharm 1054672*Benzoxazine compounds for enhancing synaptic response
Cortex Pharmaceuticals 1054673*Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors
DuPont Pharmaceuticals 1054674*Regulation of estrus and ovulation in gilts
Thorn Bioscience 1054675*Combination of estrogen and anti-estrogen
Schering 1054676*Cosmetic and dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides
Mrs, Llc 1054677*Combination of steroid and polyunsaturated fatty acids for treatment of inflammatory conditions
Research Triangle Pharmaceuticals 1054678*Use of surface active agents for the maufacture of the medicament for treatment of disorders of the middle ear
Britannia Pharmaceuticals 1054679*Compsn and method for the treatment of bladder cancer
Bioniche Life Science 1054680*The use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
Boehringer Ingelheim Vetmedica 1054681*Use of hyperforin and hyperforin-containing extracts in the treatment and prophylaxis of dementing diseases
Dr Wilmar Schwabe 1054682*Modified heat-shock protein-antigenic peptide complex
University of Miami 1054683*Method of promoting neuronal cell proliferation and differentiation
University of Southern California 1054684*Liquid crystal forms of cyclosporin
Inhale Therapeutic Systems 1054685*Pharmaceutical formulation of a didemnin compound
Pharma Mar 1054686*Expression vectors and cell lines expressing vascular endothelial growth factor D, and method of treating melanomas
Ludwig Institute for Cancer Research 1054687*Method for selecting tumours expressing HLA-G, sensitive to anticancer treatment and uses Commisariat à l'Energie
Atomique 1054688*Strategically modified hepatitis B core proteins and their derivatives
Immune Complex 1054689*Hapten-modified tumour cell membranes and their use
Thomas Jefferson University 1054690*Antibodies against human CD40
Bristol-Myers Squibb 1054692*Inhibitors of complement activation
Tanox 1054693*Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compsns prepared thereby
Selective Genetics 1054694*Soft X-ray emitting medical devices
Implant Sciences 1054695*Biaryl-acetic acid derivatives and their use as COX-2 inhibitors
Merck Frost Canada 1054857*N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sufinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
American Cyanamid 1054858*Processes and intermediates useful to make antifolates
Eli Lilly 1054859*Process for the synthesis of 1,3-diols
Warner-Lambert Export 1054860*Cytostatic agents
British Biotech Pharmaceuticals 1054861*Process for the production of organic disulphides
Albemarle 1054862*2-aminoquinoline derivatives having D4-agonistic activity
Duphar International Research 1054863*Process forthe preparation of epsilon-caprolactam
DSM; EI du Pont de Nemours 1054864*Farnesyl transferase inhibitors
AstraZeneca 1054865*Synthesis of 1-(2-sulphoethyl)-pyridinium betaine
BASF 1054866*Ativirals
Medivir 1054867*Novel substituted pyridino aryl-piperazines useful in the treatment of beign protatic hj hyperplasia
Ortho-McNeil Pharmaceutical 1054868*3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (NOS) inhibitors
Schering 1054869*Heterocyclic topoisomerase poisons
Rutgers, the State University of New Jersey 1-54870*Pyrimidines and triazines as integrin antagonists
DuPont Pharmaceuticals 1-54871*Process for preparing alkocytriazolinones
Bayer 1054872*A process for the preparation of stilbene compounds
Ciba Specialty Chemicals 1054873*Substituted aminophenyl isoxazoline derivatives useful as antimicrobials
Pharmacia & Upjohn 1054874*1m3m4-thiadiazole derivatives as KYN-OH derivatives
Pharmacia & Upjohn 1054876*Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
DuPont Pharmaceuticals 1054877*Azulenic hydroxamic acid derivatives s metalloprotein inhibitors
Roche Diagnostics 1054878*Treatment of multiple sclerosis using COP-1 and TH2-enhancing cytokines
Autoimmune 1054880*Novel sulphonamide substituted chroman derivatives useful as Beta-3 adrenoreceptor agonists
Bayer 1054881*Condensed heterocyclic system derivatives, preparation, pharmaceutical compsns containing them
Aventis Pharma 1054882*2-(pyrazolyloxy)-pyridin-3-ylacetic acid derivatives, agents containing the same, and uses thereof against noxious animal and fungal parasites
BASF 1054883*Benzofuran-4-carboxamides and their therapeutic use
Darwin Discovery 1054884*Benzisoxazole derivatives having D4-antagonistic activity
Duphar International Research 1054885*Heteroaryl amidines, methylamidines, and guanidines as protease inhibitors, in particular as urokinase inhibitors
3-Dimensional Pharmaceuticals 1054886*Bicyclic pyridine and pyrimidine derivatives as neuropeptide Y receptor antagonists
Amgen 1054887*New oxazolidinones with azol-containing tricycles
Bayer 1054889*Oligodeoxyribonucleotides comprising o6-benzylguanine and their use
The United States of America, as represented by the Secretary, Department of Health and Human Services 1054890*Prodrugs
Medivir 1054891*Azole peptidomimetics as thrombin receptor antagonists
Ortho-McNeil Pharmaceuticals 1054892*Breast cancer resistance protein (BCRP) and the DNA which encodes it
University of Maryland Baltimore 1054894*Novel peptide diagnostic reagent and kit for detection of rickettsiosis
Nilsson, Kenneth 1054895*Analgesic peptides from venom of (Grammastola spatulata) and use thereof
Zeneca 1054896*Method for purifying purines from a biological sample, and applications
Commissariat à l'Energie Atomique 1054897*Neuroprotective peptides and uses thereof
Protarga 1054898*Agents for treating human illnesses based on (b)-catenin, and the production and uses thereof
Max-Delbrück-Centrum für Molekulare Medizin 1054899*Therapeutic uses of keratinocyte growth factor-2
Human Genome Sciences 1054900*Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compsns
Institut National de la Sante et de la Recherche Medicale (INSERM) 1054901*Agents for the prevention of damages caused by stress conditions
Hadasit Medical Research Services & Development 1054902*Fishboy, a G-protein coupled receptor
SmithKline Beecham 1054903*Mucilage, a G-protein coupled receptor
SmithKline Beecham 1054904*Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised IGG
University College London 1054905*Polymerisation process with living characteristics and polymers made therefrom
EI du Pont de Nemours 1054906*Advanced active devices and methods for molecular biological analysis and diagnostics
Nanogen 1054949*HIV chemokines
The Research Foundation of the State University of New York 1054950*Solid fermentation method
Almqvist & Wallenbeck 1054951*Paclitaxel production by actinomycetes
Pharmacia & Upjohn 1054952*Novel PGSA
SmithKline Beecham 1054953*Development of regulatory cells as a means for treating autoimmune disease
Hemosol 1054954*Compsns comprising viruses and treatments for concentrating virus preparations
Schering 1054955*Lipase variants
Novo Nordisk 1054956*Alkaline bacillus amylase
Novo Nordisk 1054957*Human serine protease and serpin polypeptides
Human Genome Sciences 1054958*High efficiency methods and compsns for integrating exogenous DNA into genomic DNA of sperm
Kimron Veterinary Institute 1054959*Heteroaromatic oligoamides as affinity ligands
Merck Patent 1054960*uman short-chain TNF receptor family protein
Incyte Pharmaceuticals 1054961*Connective tissue growth factor homologs
ZymoGenetics 1-54967*Apoptosis inducing molecule II and methods of use
Human Genome Sciences 1054968*Retinoblastoma protein complexes and retinoblastoma interacting proteins
Curagen Corp 1054969*Method of producing trifluoro-3(R)-hydroxybutyric acid derivatives
Lonza 1054974*Method for designing inhibitors of serine /threonine kinases and tyrosine kinases
Vertex Pharmaceuticals 1054976*Compsns and methods for sensitising and inhibiting growth of human tumour cells
St Jude Children's Research Hospital 1054979*Prostate-associated serie protease
Incyte Pharmaceuticals 1054981*Metalloprotease-disintegrins SVPH3-13 and SVPH3-17 DNA and polypeptides
Immunex 1054982*
